February 7, 2018 / 11:03 PM / a year ago

GSK loses bid to overturn ruling allowing Louisiana's Flonase case

A federal appeals court on Wednesday said it will not reconsider a decision to allow the state of Louisiana to bring antitrust claims against GlaxoSmithKline, even though it did not opt out of a related, previous class action settlement.

The 3rd U.S. Circuit Court of Appeal in Philadelphia rejected GSK’s bid to have the full court to review a decision holding Louisiana’s sovereign immunity meant it was not bound by a deal resolving claims the drugmaker tried to delay generic versions of its allergy spray Flonase.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2E7Gzhv

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below